Femara 2.5mg (Letrozole) is a prescription medication primarily used to treat hormone receptor-positive breast cancer in postmenopausal women. It is also widely prescribed for female infertility as part of ovulation induction treatment. Each box contains 30 tablets, ideal for monthly therapy cycles.

Treats early-stage hormone-sensitive breast cancer

Used in fertility treatments to stimulate ovulation in women with PCOS or anovulation

Lowers estrogen production to reduce tumor growth

Delays or prevents recurrence of breast cancer after surgery

Non-steroidal aromatase inhibitor — safer long-term alternative to Tamoxifen

Recommended in IVF protocols and ovulation induction cycles

Always take under a doctor’s supervision.

For Breast Cancer: Take 1 tablet (2.5mg) once daily, with or without food.

For Fertility/Ovulation Induction: Typically 1 tablet daily from cycle day 3 to day 7, or as advised by a gynecologist.

Swallow whole with water — do not crush or chew.

Take at the same time daily for best results.

Breast Cancer Therapy: May continue for 5 years or more, depending on clinical response.

Fertility Use: 5-day course per menstrual cycle; repeated based on doctor’s recommendation.

Active Ingredient: Letrozole 2.5mg

Lactose monohydrate

Microcrystalline cellulose

Maize starch

Sodium starch glycolate

Magnesium stearate

Colloidal silicon dioxide

Film coating (hypromellose, iron oxide, titanium dioxide)